Dystonia as a presenting feature of the 3243 mitochondrial DNA mutation

Movement Disorders

Volumn 14, Issue 3, 1999, Pages 488-491

  Sudarsky, Lewis ^a   Plotkin, George M ^a   Logigian, Eric L ^a,b   Johns, Donald R ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Dystonia; Genetics; MELAS; Mitochondria

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BOTULINUM TOXIN; CLONAZEPAM; MITOCHONDRIAL DNA; NUCLEOTIDE; UBIDECARENONE;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSTONIA; EXERCISE; FACE MUSCLE; GENETIC ANALYSIS; HUMAN; LEG MUSCLE; MALE; MUSCLE BIOPSY; MUSCLE CRAMP; MUSCLE WEAKNESS; PERCEPTION DEAFNESS; POINT MUTATION; PRIORITY JOURNAL; PTOSIS; URINALYSIS;

ADULT; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; DYSTONIA; HUMANS; MALE; MELAS SYNDROME; PHENOTYPE; POINT MUTATION;

EID: 0033452870     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(199905)14:3<488::AID-MDS1017>3.0.CO;2-4     Document Type: Article

References (32)

1. Truong DD, Harding AE, Scaravilli F, Smith SJM, Morgan-Hughes JA, Marsden CD. Movement disorders in mitochondrial myopathies. Mov Disord 1990;5:109-117.
2. Shoffner JM. Oxidative phosphorylation diseases and movement disorders. In: Watts RL, Koller WC, eds. Movement Disorders: Neurologic Principles and Practice. New York, NY: McGraw Hill, 1997:51-71.
3. Boyson SJ. Parkinson's disease and the electron transport chain. Ann Neurol 1991;30:330-331.
4. Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann Neurol 1997;41:160-165.
5. Priller J, Scherzer CR, Faber PW, MacDonald ME, Young AB. Frataxin gene of Friedreich's ataxia is targeted to mitochondria. Ann Neurol 1997;42:265-269.
6. Ozelius L, Hewett JW, Page CE, et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997;17:40-48.
7. Warner IT, Jarman P. The molecular genetics of the dystonias. J Neurol Neurosurg Psychiatry 1998;4:427-429.
8. Leube B, Hendgen T, Kessler KR, Knapp M, Benecke R, Auburger G. Sporadic focal dystonia in Northwest Germany: molecular basis on chromosome 18p. Ann Neurol 1997;42:111-114.
9. Almasy L, Bressman SB, Raymond D, et al. Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families. Ann Neurol 1997;42:670-673.
10. Berkovic SF, Andermann F, Carpenter S, Wolfe LS. Progressive myoclonus epilepsies: specific causes and diagnosis. N Engl J Med 1986;315:296-305.
11. Shoffner JM, Kaufman A, Koontz D, et al. Oxidative phosphorylation diseases and cerebellar ataxia. Clin Neurosci 1995;3:43-53.
12. Ekbom K. Hereditary ataxia, photomyoclonus, skeletal deformities and lipoma. Acta Neurol Scand 1975;51:393-404.
13. Johns DR. Mitochondrial DNA and disease. N Engl J Med 1995; 333:638-644.
14. Nelson I, Hanna MG, Alsanjari N, Scaravilli F, Morgan-Hughes JA, Harding AE. A new mitochondrial DNA mutation associated with progressive dementia and chorea: a clinical, pathological, and molecular genetic study. Ann Neurol 1995;37:400-403.
15. Schapira AHV. Evidence for mitochondrial dysfunction in Parkinson's disease: a critical appraisal. Mov Disord 1994;9:125-138.
16. Wooten GF, Currie LJ, Bennett JP, et al. Maternal inheritance in Parkinson's disease. Ann Neurol 1997;41:265-268.
17. Novotny EJ, Singh G, Wallace DC, et al. Leber's disease and dystonia: a mitochondrial disease. Neurology 1986;36:1053-1060.
18. Pincus JH. Subacute necrotizing encephalomyelopathy (Leigh's disease). Dev Med Child Neurol 1972;14:87-101.
19. Macaya A, Munell F, Burke RE, DeVivo DC. Disorders of movement in Leigh syndrome. Neuropediatrics 1993;24:60-67.
20. Santorelli FM, Shanske S, Macaya A, DeVivio DC, DiMauro S. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol 1993;34:827-834.
21. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 1994;91:6206-6210.
22. DeVries DD, Went LN, Bruyn GW, et al. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dysphonia. Am J Hum Genet 1996;58:703-711.
23. Meire FM, Van Coster R, Cochaux P, Obermaier-Kusser B, Candaele C, Martin JJ. Neurological disorders in members of families with Leber's hereditary optic neuropathy (LHON) caused by different mitochondrial mutations. Ophthalmic Genet 1995;16:119-126.
24. Marsden CD, Lang AE, Quinn NP, McDonald WI, Abdallat A, Nimi S. Familial dystonia and visual failure with striatal CT lucencies. J Neurol Neurosurg Psychiatry 1986;49:500-509.
25. Donnet A, Guinot H, Pellissier JF, et al. Dystonie segmentaire et encephalomyopathie mitochondriale. Rev Neurol (Paris) 1992; 148:51-53.
26. Nigro MA, Martens ME, Awerbuch GI, Peterson PL, Lee CP. Partial cytochrome b deficiency and generalized dystonia. Pediatr Neurol 1990;6:407-410.
27. Benecke R, Strumper P, Weiss H. Electron transfer complex I defect in idiopathic dystonia. Ann Neurol 1992;32:683-686.
28. Schapira AHV, Warner T, Gash MT, Cleeter JWH, Marinho CFM, Copper JM. Complex I function in familial and sporadic dystonia. Ann Neurol 1997;41:556-559.
29. Goto Y, Nonaka I, Horai S. A mutation in the tRNA (Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-653.
30. Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992;42:545-550.
31. Ciafaloni E, Ricci E, Shanske S, et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992;31:391-398.
32. Moraes CT, Ciacci F, Silvestri G, et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord 1993;3:43-50.